Urinary Biomarker Test XBCM Reduces Cystoscopy in High-Grade NMIBC Surveillance
XBCM urinary biomarker test achieves 91% sensitivity and 99% NPV while reducing cystoscopy burden by 56% in high-grade NMIBC surveillance.
Urinary Biomarker Test XBCM Reduces Cystoscopy in High-Grade NMIBC Surveillance Read More ยป